<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Celularity, Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=29501></link><description><![CDATA[Celularity, Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 16:52:54 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform]]></title><link>https://www.newswire.co.kr/newsRead.php?no=854898</link><description><![CDATA[WARREN, N.J.--(Business Wire/Korea Newswire)--Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, Unite...]]></description><pubDate>Tue, 22 Aug 2017 15:20:00 +0900</pubDate></item><item><title><![CDATA[셀룰래리티, 획기적인 태반 연구 및 치료 플랫폼 조성 가속화]]></title><link>https://www.newswire.co.kr/newsRead.php?no=854900</link><description><![CDATA[워런, 뉴저지--(Business Wire/뉴스와이어)--새롭게 창립된 생명공학 회사인 셀룰래리티(Celularity, Inc.)가 암과 만성 및 퇴행성 질환 치료에서 충족되지 않은 의료적 요구에 대응하기 위해 세포 및 조직 재생치료를 위한 노력을 가속화 한다고 21일 발표했다.   셀룰래리티는 소렌토 테라퓨틱스(Sorrento Therapeutics), 유나이티드 테라퓨틱스 코퍼레이션(United Therapeutics Corporation), 휴먼 론제비티(Human L...]]></description><pubDate>Tue, 22 Aug 2017 15:20:00 +0900</pubDate></item></channel></rss>